Diakines program (Biotherapix)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameDiakines program (Biotherapix)
Drug Alias Namechemokine receptor blocker (Biotherapix)Btx-501Btx-502
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionChemokine receptors antagonists
TargetsChemokine receptors
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiotherapix SLU
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiotherapix SLU
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A